SCHEEFF D E,BOURNE P E.Structural evolution of the protein kinase-like superfamily[J].PLoS Computational Biology,2005,1(5):359-381.
[2]
ENGELMAN J A,LUO J,CANTLEY L C.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J].Nature Reviews Genetics,2006,7:606-619.
[3]
STOYANOV B,VOLINIA S,HANCK T,et al.Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase[J].Science,1995,269:690-693.
[4]
JIA S,LIU Z,ZHANG S,et al.Essential roles of PI(3)K-p110beta in cell growth,metabolism and tumorigenesis[J].Nature,2008,454:776-779.
[5]
STEPHENS L R,EGUINOA A,ERDJUMENT-BROMAGE H,et al.The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor,p101[J].Cell,1997,89(1):105-114.
[6]
PACOLD M E,SUIRE S,PERISIC O,et al.Crystal structure and functional analysis of Ras binding to its effector phosphatidylinositol 3-kinase gamma[J].Cell,2000,103(6):931-943.
[7]
VADAS O,BURKE J E,ZHANG X X,et al.Structural basis for activation and inhibition of class Ⅰ phosphoinositide 3-kinases[J].Science Signal,2011,4(195):1-12.
[8]
MATSAKAS A,PATEL K.Skeletal muscle fibre plasticity in response to selected environmental and physiological stimuli[J].Histology and Histopathology,2009,24(5):611-629.
[9]
DUPONT E,BERNARD C C,BASTIDE B,et al.Electrostimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK[J].American Journal of Physiology:Regulatory,Integrative and Comparative Physiology,2011,300:408-417.
[10]
LUO J,SOBKIW C L,HIRSHMAN M F,et al.Loss of class ⅠA PI3K signaling in muscle leads to impaired muscle growth,insulin response,and hyperlipidemia[J].Cell Metabolism,2006,3:355-366.
[11]
ROFFE S,HAGAIA Y,PINES M,et al.Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells:effect on myotube fusion[J].Experimental Cell Research,2010,316:1601-1609.
[12]
BAVIERA A M,ZANON N M,NAVEGANTES L C C,et al.Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle[J].Molecular and Cellular Endocrinology,2010,315(1/2):104-112.
[13]
GLASS D J.Molecular mechanisms modulating muscle mass[J].Trends in Molecular Medicine,2003,9(8):345-350.
[14]
ZHANG H,STALLOCK J P,JOYCE C N,et al.Regulation of cellular growth by the drosophila target of rapamycin dTOR[J].Genes and Development,2000,14:2712-2724.
[15]
KUBICA N,BOLSTER D R,FARRELL P A,et al.Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2B epsilon mRNA in a mammalian target of rapamycin-dependent manner[J].The Journal of Biological Chemistry,2005,280(9):7570-7580.
[16]
VYAS D R,SPANGENBURG E E,ABRAHA T W,et al.GSK-3beta negatively regulates skeletal myotube hypertrophy[J].American Journal of Physiology,2002,283(2):545-551.
[17]
MILLER S,TAVSHANJIAN B,OLEKSY A,et al.Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34[J].Science,2010,327:1638-1642.
[18]
KUMAR C C,MADISON V.AKT crystal structure and AKT-specific inhibitors[J].Oncogene and Oncogene Reviews,2005,24(50):7493-7501.
[19]
KAWANO Y,KYPTA R.Secreted antagonists of the Wnt signalling pathway[J].Journal of Cell Science,2003,116:2627-2634.
[20]
ROCHAT A,FERNANDEZ A,VANDROMME M,et al.Insulin and Wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy[J].Molecular Biology of the Cell,2004,15:4544-4555.
